Stay updated on ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial page.

Latest updates to the ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.6.5 is now displayed on the page, replacing the previous v3.6.4. This indicates a site version update that does not modify the study content or how users interact with the page.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe website version was updated from v3.6.3 to v3.6.4, representing a maintenance/patch release. This change does not modify the study content or data shown on the page.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3, indicating an underlying platform version bump. This appears to be a software update behind the scenes rather than a change to the study page content.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, indicating a backend/software update. The study details and user-facing content remain unchanged.SummaryDifference0.1%

- Check77 days agoChange DetectedAdded a recruitment notice 'No longer looking for participants' and new help sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'). Updated the revision tag from v3.5.5 to v3.6.0 and changed the heading 'Intervention / Treatment' to 'Intervention/Treatment'.SummaryDifference0.5%

- Check84 days agoChange DetectedThe page now displays a newer revision tag (v3.5.5) replacing the previous v3.5.4, indicating an update to the page template or underlying system.SummaryDifference0.1%

Stay in the know with updates to ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial page.